LESS CANCER

LESS CANCER Next Generation Choices Foundation, 501c3 AKA Less Cancer. The organization seeks solutions through education and policy.

Messages through messenger are not checked. Please feel free to reach out to [email protected].

09/02/2026

The worldwide toll demonstrates both the danger of measles and the lifesaving power of vaccination.
Historically lower numbers in the United States do not mean measles is harmless. They demonstrate what vaccination and strong public-health systems accomplish. As of August 27, the United States had already reported 2,903 confirmed measles cases in 2026.
If you have questions about the MMR vaccine or other vaccinations, ask your physician or pediatrician which vaccines are recommended for you and your family.
Follow the evidence. Listen to physicians, scientists and public-health experts.
Sources: World Health Organization and Centers for Disease Control and Prevention

08/29/2026

This needs attention now.
New Medicaid work and reporting requirements must generally be in place by January 1, 2027. States will decide important parts of how exemptions are identified and verified.
People undergoing active cancer treatment, including surgery and other invasive treatment, should not risk losing Medicaid because they missed a reporting requirement.
Some people with serious medical needs may qualify as medically frail, but implementation can vary. Cancer patients should not have to guess whether they are protected.
Ask your state lawmakers to make active cancer treatment a clear, simple exemption.
Find your state lawmakers at USA.gov.

08/27/2026

BREAKTHROUGH IN PANCREATIC CANCER
The FDA has approved a new oral targeted therapy for certain patients with metastatic pancreatic cancer.
This is not a cure, and it is not for every person with pancreatic cancer. But it is a major step forward for a disease that has desperately needed more treatment options.
And a reminder: just because we do not always understand the science does not mean extraordinary things are not happening because of it.
Research matters. Expertise matters. Investment in science matters.
Thank you, science.
Read more directly from the FDA:
“FDA Approves First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer”
FDA.gov

08/26/2026

Public health is easiest to overlook when it is working.
We are seeing, in real time, what happens when systems designed to protect people are weakened or dismissed as waste.
Safe food. Clean water. Disease surveillance. Prevention. Outbreak response.
These are not abstract ideas. They are protections.
Public health is for everyone.

08/25/2026

Measles was once pushed to the margins in the U.S. because vaccination worked. Now cases are rising again, and people are being hospitalized and dying.
If you or your child are not vaccinated, talk with your physician. Your decision may affect people who cannot protect themselves.
Prevention works best when we remember what it prevented.

08/24/2026
08/24/2026

Before you share health information:
Check the source.
Find the published evidence.
Look for qualified physicians and scientists.
See whether the findings have been replicated.
Influence is not expertise.
One study is not consensus.
For medical advice, always talk to your physician.
Bad information can do real harm.

08/20/2026

Better health is not built by forcing wellness, prevention, vaccines and medicine into opposing camps. Ask your doctor how they work together.

Good news deserves attention too.A personalized mRNA cancer vaccine has passed a major Phase 3 test in melanoma. When ad...
08/19/2026

Good news deserves attention too.
A personalized mRNA cancer vaccine has passed a major Phase 3 test in melanoma. When added to Keytruda, it significantly reduced the risk of melanoma returning or spreading compared with Keytruda alone.
The treatment is still investigational and is not yet approved for routine use, but this is an important step forward.
This is what decades of science builds.
More information: See link in story and bio and link below on other platforms

https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/

Address

98 Alexandria Pike Suite 22
Warrenton, VA
20186

Alerts

Be the first to know and let us send you an email when LESS CANCER posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to LESS CANCER:

Shortcuts

Share